These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18180847)

  • 1. [Efficacy of an intermediate action insulin in diabetics non-respondents to oral treatment].
    Díaz C J; Moneada V S; Orriols W M; Durruty A P
    Rev Med Chil; 2007 Oct; 135(10):1358-60. PubMed ID: 18180847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lantus is superior in BOT (basic oral therapy) to standard mixed insulin].
    Krankenpfl J; 2004; 42(5-6):172. PubMed ID: 15527234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human insulin-induced lipoatrophy.
    Felner EI
    J Pediatr; 2003 Apr; 142(4):448. PubMed ID: 12712066
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J; Gao S; Dai WS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G; Laurenti O; Moretti A
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First report of hypoglycemia secondary to dandelion (Taraxacum officinale) ingestion.
    Goksu E; Eken C; Karadeniz O; Kucukyilmaz O
    Am J Emerg Med; 2010 Jan; 28(1):111.e1-2. PubMed ID: 20006217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of type II diabetes using homologous intermediate-acting insulin combinations. Comparison of the effectiveness of 5 commonly used preparations].
    Haupt E; Hoppe FU; Rudolf R; Bamberg E
    Dtsch Med Wochenschr; 1987 Jul; 112(31-32):1209-12. PubMed ID: 3301260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotted dermopathy in a diabetic patient due to insulin allergy.
    Maheshwari M; Goyal D; Desouza P; Goyal RK
    J Assoc Physicians India; 2004 Nov; 52():926-7. PubMed ID: 15906848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G; Strange P
    Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C; Hernández Herrero C; Rivas Fernández M
    Diabet Med; 2008 Aug; 25(8):916-23. PubMed ID: 18959604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immediate protamine sulphate allergy in an insulin-treated diabetic patient].
    Petäys T; Kiistala R; Mäkinen-Kiljunen S
    Duodecim; 1999; 115(5):517-20. PubMed ID: 11830901
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C; Jung R; Hofmann U
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
    Monami M; Marchionni N; Mannucci E
    Diabetes Res Clin Pract; 2008 Aug; 81(2):184-9. PubMed ID: 18495286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
    Singh KP; Periyandavar I; Rajadhyaksha GC; Jayaram S; Mishra AB; Kinagi S; Sharma A; Baliga VP
    J Indian Med Assoc; 2007 Jun; 105(6):344, 346, 350. PubMed ID: 18232183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics.
    Fang YM; MacKeen D; Egan JF; Zelop CM
    J Matern Fetal Neonatal Med; 2009 Mar; 22(3):249-53. PubMed ID: 19330710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.